Growth of Ligand-Target Interaction Data in ChEMBL Is Associated with Increasing and Activity Measurement-Dependent Compound Promiscuity
暂无分享,去创建一个
Jürgen Bajorath | Ye Hu | J. Bajorath | Ye Hu
[1] G. Bemis,et al. The properties of known drugs. 1. Molecular frameworks. , 1996, Journal of medicinal chemistry.
[2] Yong-Jin Xu,et al. Using Molecular Equivalence Numbers to Visually Explore Structural Features that Distinguish Chemical Libraries. , 2002 .
[3] P. Shannon,et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.
[4] G. V. Paolini,et al. Global mapping of pharmacological space , 2006, Nature Biotechnology.
[5] Michael J. Keiser,et al. Relating protein pharmacology by ligand chemistry , 2007, Nature Biotechnology.
[6] R. Solé,et al. Data completeness—the Achilles heel of drug-target networks , 2008, Nature Biotechnology.
[7] A. Hopkins. Network pharmacology: the next paradigm in drug discovery. , 2008, Nature chemical biology.
[8] J. Bajorath,et al. Systematic computational analysis of structure-activity relationships: concepts, challenges and recent advances. , 2009, Future medicinal chemistry.
[9] Andreas Bender,et al. Databases: Compound bioactivities go public , 2010 .
[10] Jürgen Bajorath,et al. Polypharmacology Directed Compound Data Mining: Identification of Promiscuous Chemotypes with Different Activity Profiles and Comparison to Approved Drugs , 2010, J. Chem. Inf. Model..
[11] J. Bajorath,et al. Systematic analysis of public domain compound potency data identifies selective molecular scaffolds across druggable target families. , 2010, Journal of medicinal chemistry.
[12] J. Bajorath,et al. Activity landscape representations for structure-activity relationship analysis. , 2010, Journal of medicinal chemistry.
[13] J. Bajorath,et al. BindingDB and ChEMBL: online compound databases for drug discovery , 2011, Expert opinion on drug discovery.
[14] Pekka Tiikkainen,et al. Analysis of Commercial and Public Bioactivity Databases , 2012, J. Chem. Inf. Model..
[15] Sean Ekins,et al. Towards a gold standard: regarding quality in public domain chemistry databases and approaches to improving the situation. , 2012, Drug discovery today.
[16] John P. Overington,et al. ChEMBL: a large-scale bioactivity database for drug discovery , 2011, Nucleic Acids Res..
[17] M. Gilson,et al. Public domain databases for medicinal chemistry. , 2012, Journal of medicinal chemistry.
[18] Huimin Zhao,et al. Customized optimization of metabolic pathways by combinatorial transcriptional engineering , 2012, Nucleic acids research.